The efficacy of Chinese Covid-19 vaccines is “not high” and authorities are weighing options to bolster protection — including mixing different shots, China’s top disease control official has said.
Top Investments for 2025: A Focus on the S&P 500
As we move into 2025, the S&P 500 continues to be a cornerstone of investment strategies, offering insights into the U.S. stock market’s health. Following